Top

Reactions Weekly

Published in:

01-01-2023 | Clonidine | Case report

Oxcarbazepine/topiramate

Neuroleptic malignant syndrome following drug withdrawal: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Dang S, et al. (133) Neuroleptic Malignant Syndrome from Oxcarbazepine & Topiramate Withdrawal: A Rare Case Report. Journal of the Academy of Consultation-Liaison Psychiatry 63 (Suppl. 2): S178 abstr. 133, Nov 2022. Available from: URL: http://doi.org/10.1016/j.jaclp.2022.10.135 [abstract]

Title: Oxcarbazepine/topiramate
Neuroleptic malignant syndrome following drug withdrawal: case report
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Clonidine
Meningoencephalitis
Malignant Hyperthermia
Malignant Hyperthermia
Oxcarbazepine
Topiramate
Amantadine
Lorazepam
Dantrolene
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-31777-2

At a glance: The STEP trials

Springer Medicine

Oxcarbazepine/topiramate

Neuroleptic malignant syndrome following drug withdrawal: case report

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Dexamethasone/favipiravir

Lorazepam

Ipilimumab/nivolumab

Multiple drugs

Enoximone/norepinephrine/warfarin

Dasatinib/imatinib